TY - JOUR
T1 - Agonist-induced endocytosis and receptor phosphorylation mediate resensitization of dopamine D2 receptors
AU - Cho, Dongim
AU - Zheng, Mei
AU - Min, Chengchun
AU - Ma, Lan
AU - Kurose, Hitoshi
AU - Park, Jae H.
AU - Kim, Kyeong Man
PY - 2010/3
Y1 - 2010/3
N2 - The regulatory mechanisms and functional roles of agonist-induced internalization of G proteincoupled receptors (GPCRs) were analyzed using mutant dopamine D2 receptors (D2Rs) in which all possible GPCR kinase (GRK) phosphorylation sites were mutated or the affinity for β-arrestins was altered. Agonist-induced internalization of D2Rs involved a phosphorylation-dependent component, which was mediated by serine/threonine (S/T) residues in the second loop and T225 in the third loop, and a phosphorylation-independent component. GRK2-mediated enhancement of the internalization and inhibition of D2R signaling did not involve receptor phosphorylation, and only the former required the enzymatic activity of GRK2. The phosphorylation-deficient mutant (D2R-intracellular loop 2/3) recycled more slowly and showed more agonist-induced desensitization than did the wild-type D2R, suggesting that receptor phosphorylation mediates the recycling of the internalized receptors and enhances receptor resensitization. Blockade of the agonist-induced internalization of D 2R-intracellular loop 2/3 provoked desensitization as in wild-type D2R, suggesting that certain cellular processes other than receptor dephosphorylation occurring within the endocytic vesicle are responsible for the resensitization of D2R. When dissociation between D2R and β-arrestin was inhibited or when the expression of cellular β-arrestins was decreased, agonist-induced desensitization of D 2R did not occur, suggesting that dissociation from β-arrestin is the main cellular process required for resensitization of D2R and is achieved through agonist-induced internalization. These results indicate that, in the regulation of some GPCRs, phosphorylation-independent association with β-arrestin plays a major role in agonistinduced desensitization.
AB - The regulatory mechanisms and functional roles of agonist-induced internalization of G proteincoupled receptors (GPCRs) were analyzed using mutant dopamine D2 receptors (D2Rs) in which all possible GPCR kinase (GRK) phosphorylation sites were mutated or the affinity for β-arrestins was altered. Agonist-induced internalization of D2Rs involved a phosphorylation-dependent component, which was mediated by serine/threonine (S/T) residues in the second loop and T225 in the third loop, and a phosphorylation-independent component. GRK2-mediated enhancement of the internalization and inhibition of D2R signaling did not involve receptor phosphorylation, and only the former required the enzymatic activity of GRK2. The phosphorylation-deficient mutant (D2R-intracellular loop 2/3) recycled more slowly and showed more agonist-induced desensitization than did the wild-type D2R, suggesting that receptor phosphorylation mediates the recycling of the internalized receptors and enhances receptor resensitization. Blockade of the agonist-induced internalization of D 2R-intracellular loop 2/3 provoked desensitization as in wild-type D2R, suggesting that certain cellular processes other than receptor dephosphorylation occurring within the endocytic vesicle are responsible for the resensitization of D2R. When dissociation between D2R and β-arrestin was inhibited or when the expression of cellular β-arrestins was decreased, agonist-induced desensitization of D 2R did not occur, suggesting that dissociation from β-arrestin is the main cellular process required for resensitization of D2R and is achieved through agonist-induced internalization. These results indicate that, in the regulation of some GPCRs, phosphorylation-independent association with β-arrestin plays a major role in agonistinduced desensitization.
UR - http://www.scopus.com/inward/record.url?scp=77249103669&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77249103669&partnerID=8YFLogxK
U2 - 10.1210/me.2009-0369
DO - 10.1210/me.2009-0369
M3 - Article
C2 - 20160122
AN - SCOPUS:77249103669
SN - 0888-8809
VL - 24
SP - 574
EP - 586
JO - Molecular Endocrinology
JF - Molecular Endocrinology
IS - 3
ER -